De novo biosynthesis of eriocitrin in Saccharomyces cerevisiae through deep learning-guided enzyme screening and systematic metabolic engineering
Authors:
- Qiyuan LuQLQiyuan Lu
- Xinjia TanXTXinjia Tan
- Siqi ZhangSZSiqi Zhang
- Yongtong WangYWYongtong Wang
- Yifei ZhaoYZYifei Zhao
- Juan LiuJLJuan Liu
- Fanglin HuFHFanglin Hu
- Shasha ZuoSZShasha Zuo
- Jiaxu ChenJCJiaxu Chen
- Liusha FanLFLiusha Fan
- Shenghua DingSDShenghua Ding
- Zhiqiang XiaoZXZhiqiang Xiao
Open Access
- 1 September 2026
- journal article
- Published by KEAI Publishing in Synthetic and Systems Biotechnology
- Vol. 13, 143-153
Abstract
Eriocitrin, a flavanone-7-O-disaccharide known for its antioxidant and anti-inflammatory properties, holds considerable promise for use in functional foods and pharmaceuticals. However, its large-scale production is constrained by the limitations of conventional plant extraction, including low abundance of active compounds and seasonal variability. Here, we established a de novo biosynthetic pathway for eriocitrin from glucose in engineered Saccharomyces cerevisiae through combinatorial metabolic engineering. First, to verify the feasibility of glycosylation in the eriocitrin synthesis process, two highly efficient flavonoid-7-O-glucosyltransferases were identified using an integrated bioinformatics and deep learning approach. Subsequently, through the reconstruction of the UDP-rhamnose synthesis pathway and enhancement of the key glycosylation precursor UDP-glucose supply, an eriocitrin titer of 147.9 mg/L was achieved following supplementation with 300 mg/L eriodictyol. To further achieve the de novo synthesis of eriocitrin, an eriodictyol-producing strain was developed by screening the optimal F3′H/CPR pair, engineering promoters, and pathway integration, achieving an eriodictyol titer of 237.8 mg/L. Finally, combining the eriodictyol-producing chassis strain with the previously optimized glycosylation module enabled the de novo production of eriocitrin, reaching a titer of 30.5 mg/L. This work demonstrates a proof-of-concept for microbial production of flavonoid disaccharides, providing a foundation for a sustainable and scalable supply of eriocitrin.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFD2100804)
- National Natural Science Foundation of China (32330084)
- National Natural Science Foundation of China (2024-DTZD-001)
- Jiangsu Agricultural Science and Technology Innovation Fund
This publication has 58 references indexed in Scilit:
- Promoting the glycosylation of drug-like natural products in a Saccharomyces cerevisiae chassis by deletion of endogenous glycosidasesBioresource Technology, 2025
- ALG5 downregulation inhibits osteogenesis and promotes adipogenesis by regulating the N-glycosylation of SLC6A9 in osteoporosisCellular and Molecular Life Sciences, 2025
- Metabolic engineering of Yarrowia lipolytica for high-level production of scutellarinBioresource Technology, 2023
- Effect of chromosomal integration on catalytic performance of a multi‐component P450 system in Escherichia coliBiotechnology and Bioengineering, 2023
- Eriocitrin: A review of pharmacological effectsBiomedicine & Pharmacotherapy, 2022
- Microbial cell factories for the production of flavonoids–barriers and opportunitiesBioresource Technology, 2022
- Fine‐tuning the (2S)‐naringenin synthetic pathway using an iterative high‐throughput balancing strategyBiotechnology and Bioengineering, 2019
- Construction of a novel UDP-rhamnose regeneration system by a two-enzyme reaction system and application in glycosylation of flavonoidBiochemical Engineering Journal, 2018
- The FKS family genes cause changes in cell wall morphology resulted in regulation of anti-autolytic ability in Saccharomyces cerevisiaeBioresource Technology, 2018
- Structural and biochemical insights into nucleotide–rhamnose synthase/epimerase–reductase from Arabidopsis thalianaBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2015